From Fragmented Data to Decision-Grade Evidence: Unlocking the Potential of UK RWD to Accelerate and De-Risk Development and Commercialisation

• Explore how growing receptivity to RWE from key UK regulators is driving demand for UK RWD, creating new opportunities for pharma to engage with greater confidence
• Learn how a growing network of leading UK health systems is powering a unique research database to deliver fit-for-purpose, near real time, multi-modal datasets for impactful evidence generation
• Consider select case studies demonstrating how clinically informed, longitudinal and linked UK RWD unlocks new RWE opportunities in an era of precision medicine and patient centricity

Speakers:

Tom Frusher

Chief Commercial Officer

Arcturis Data